Natixis/ODDO-BHF has been ranked #1* IPO Bookrunner in France in 2018, both in number of deals and in issuance volumes. This confirms our expertise in Equity Capital Markets, notably acting as le...
Natixis/ODDO-BHF has been ranked #1* IPO Bookrunner in France in 2018, both in number of deals and in issuance volumes. This confirms our expertise in Equity Capital Markets, notably acting as le...
Natixis recently led a 180m convertible bond issue for GENFIT, which develops therapeutic solutions in metabolic and inflammatory diseases that notably affect the liver. This issue is the largest ...